The British Irish Hearing Instrument Manufacturers Association (BIHIMA) reports that the third quarter 2021 has set a second consecutive record as the hearing instrument market continues to recover from the effects of the pandemic.
The UK private market sales have increased by 9% from Q2 to Q3 and are up by 36% on the third quarter of 2019.
The Irish market has shown significant growth, with unit sales up 58% on Q1 this year, and up 79% on Q3 in 2019.
There has been a good recovery in the NHS market, with unit sales of over 350k in Q3 this year, up 41% on the previous quarter, but still down 8% on Q3 2019.
The UK private sector is becoming more sustainable – the UK non-NHS sector has moved away from traditional zinc air batteries to li-ion rechargeable batteries with 68% of all sales now rechargeable: fewer batteries will be required, helping conserve valuable resources.
The NHS sector is yet to make the switch.
“The industry is making strides to protect the environment as we move towards increased use of rechargeable batteries, most significantly in the UK private sector. We’re pleased to see the NHS market is making a strong recovery and that, for the second consecutive quarter, we’ve hit record highs in both the UK private and Irish market.”
–Paul Surridge, BIHIMA Chairman
Download the full market data results here.
As a voice for hearing technology, BIHIMA regularly monitors the market and releases the results of its members every quarter.
About BIHIMA:
BIHIMA represents the hearing instrument manufacturers of Britain and Ireland, working in partnership with other professional, trade, regulatory and consumer organisations within the health care and charitable sectors. We raise consumer awareness about the latest hearing technology, and aim to influence government and policy makers to improve the lives of people with hearing difficulties.
Interested to keep up to date with the latest hearing instrument market information? Sign up to receive BIHIMA’s quarterly results here.
Source: BIHIMA
